Pharmacist-led Preoperative Optimisation
Research type
Research Study
Full title
A complex intervention to consider if patients with Parkinson’s disease (a high risk disease) or who are taking warfarin (a high risk medicine) would benefit from a preoperative review by a pharmacist prior to having an elective procedure.
IRAS ID
273250
Contact name
Sophie E Blow
Contact email
Sponsor organisation
Leeds Teaching Hospitals NHS Trust
Duration of Study in the UK
0 years, 8 months, 30 days
Research summary
This study is aimed at improving the care of patients who are admitted for elective surgery. At present patients requiring an elective surgical procedure with a general anaesthetic attend pre-assessment clinics (POAC) to assess their fitness for anaesthetic. The study intervention is an appointment with a pharmacist to review medicines and will take place prior to a patient’s admission for surgery but after their POAC visit. \nThis intervention will be piloted in two cohorts of patients; one cohort taking the high risk medicine warfarin and in a cohort of patients with a high risk disease, Parkinson’s disease. It is known that inappropriate or lack of medicines management in these cohorts can result in delayed surgery, poorer surgical outcomes and can affect a patient’s recovery after surgery. \nDue to patient numbers, and a lack of research in this area a controlled trial cannot be performed. This complex intervention will review if the intervention to optimise medication taking around the time of surgery, can improve patients surgical outcomes and recovery. \nPatients in this study will be provided with an individualised perioperative medication plan. This will include which medicines can be taken on the morning of surgery and how to take medicines after their surgery. If required, changes to the patients regular medicines will be made by the pharmacist, this may include changing from a tablet to a patch if a patient is likely to have difficulty swallowing around the time of their surgery. All decisions about medicines will be discussed with the patient and communicated with all members of the healthcare team.
REC name
Yorkshire & The Humber - Bradford Leeds Research Ethics Committee
REC reference
19/YH/0444
Date of REC Opinion
30 Dec 2019
REC opinion
Favourable Opinion